+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-09-29Number of Pages: 170

Life Science Instrumentation Market (Technique - Spectroscopy, Chromatography, PCR, Immunoassays, Clinical Chemistry Analyzers, Flow Cytometry; Application - Pharmaceutical, Research; End Use - Research Institutes, Pharmaceutical and Biotech, Hospitals, Diagnostic Laboratories, Forensic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022

Global Life Science Instrumentation Market: Snapshot

The life science instrumentation market has exhibited a smooth growth trajectory in recent years due to the growing utilization of the sector in booming industries such as healthcare and pharmaceuticals. The market is set to grow in the coming years at a steady growth rate due to the growing government support afforded to the life sciences sector in a number of countries and the rising rate of technological advancement in the sector. The life sciences instrumentation sector has also benefited from the growing medical devices sector and is likely to exhibit a steady growth trajectory in the coming years. 

According to Transparency Market Research, the global life sciences instrumentation market is expected to rise from a valuation of US$57.4 bn to US$85.1 bn over the 2017-2022 forecast period, exhibiting a strong 8.2% CAGR therein. 

 

life science instrumentation market

 

Spectroscopy to Remain Leading Technique

By technique, the global life sciences instrumentation market is segmented into spectroscopy, PCR, chromatography, immunoassays, flow cytometry, clinical chemistry analyzers, and others. Spectroscopy is likely to remain the leading contributor to the global life science instrumentation market in the coming years due to its widespread use in the life sciences sector and its rising utility in the healthcare sector. Spectroscopy had a valuation of US$19.2 bn in 2017 and is likely to rise to US$28.5 bn by 2022 at a steady 8.2% CAGR. Spectroscopy is a key part of blood testing, which is likely to become increasingly important in the healthcare sector in the coming years, enabling steady dominance of the spectroscopy technique in the global life science instrumentation market. 

North America to Dominate Global Life Science Instrumentation Market

North America is likely to remain the leading geographical segment of the global life science instrumentation market in the coming years. The North America life science instrumentation market has benefited from the strong government support for advancement of the life sciences sector in developed countries such as the U.S. and Canada, which are also home to several leading players in the life sciences sector due to the easy availability of advanced technology and research facilities. The North America life science instrumentation market was valued at US$18.6 bn in 2017 and is likely to reach US$28 bn by 2022 at an 8.5% CAGR. 

Europe to Contribute Significantly to Global Life Science Instrumentation Market

Europe is also likely to be a major regional market for life science instrumentation market players in the coming years due to the rapid growth of the life sciences sector in the region. The steady adoption of life science advances in the healthcare sector in the highly developed countries in Western Europe has been beneficial for the life science instrumentation market in Europe. The strong presence of the medical devices industry and the increasing adoption of innovations in the manufacturing sector in Europe is also beneficial for the life sciences instrumentation market in the region, as this will enable steady incorporation of technological advances in the life science instrumentation market. 

Pharmaceutical and Biotech Companies to Dominate Demand 

Pharmaceutical and biotech companies are expected to be the leading end users of the life science instrumentation market in the coming years. The pharmaceuticals sector has benefited from the growing demand in emerging regions, which has driven investment in its foundational components such as life sciences instrumentation. 

Competitive Dynamics

Leading players in the global life science instrumentation market include Becton, Dickinson, and Company, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Perkinelmer Inc., GE Healthcare, Merck KGaA, Bruker Corporation, Hitachi High-Technologies Corporation, Eppendorf AG, and Shimadzu Corporation. The life science instrumentation market is likely to be intensely competitive in the coming years due to the growing commercial scope of the market. 

Global Life Science Instrumentation Market: Overview

The global life science instrumentation market report presents a comprehensive picture of a rapidly growing market. The life science instrumentation market has experienced smooth growth in the last few years due to growing support from a number of governments and is likely to further grow at a solid rate in the coming years. The report assesses all components of the global life science instrumentation market in order to familiarize readers with the workings of the market in detail. The rapid growth of the life science instrumentation market has enabled the entry of several new players in the market in recent years, which has changed the dynamics of the market. The rising demand for regulatory control over the life sciences sector also has the potential to affect the global life science instrumentation market in the long run.

The global life sciences instrumentation market was valued at US$57.4 bn in 2017. According to Transparency Market Research, the market is expected to rise to a value of US$85.1 bn by 2022, exhibiting a strong 8.2% CAGR.

Global Life Science Instrumentation Market: Dynamics

The drivers and restraints affecting the global life sciences instrumentation market are described in detail in the report. The global life sciences instrumentation market has taken on an important role in several sectors in recent years, leading to a confluence of several factors having a telling impact on the market’s growth trajectory. The likely effect of the most important drivers and restraints for the life sciences instrumentation market is studied in the report in order to provide readers with a clear idea of how the market is likely to develop over the coming years. Major drivers working for the global life sciences instrumentation market include the rising government support to the life sciences sector and the rising utilization of advances in the life sciences sector in the healthcare and pharmaceutical industry.

Global Life Science Instrumentation Market: Segmentation

The report presents a detailed look at all leading segments of the global life sciences instrumentation market in order to provide readers with a clear picture of the granular structure of the market. The report segments the global life sciences instrumentation market by end use, application, technique, and geography and presents historical figures regarding the leading segments to illustrate the historical growth trajectory of the segments as well as their growth prospects in the coming years.

By technique, the report segments the global life sciences instrumentation market into spectroscopy, chromatography, PCR, immunoassays, clinical chemistry analyzers, flow cytometry, and others. Spectroscopy is the largest segment of the global life sciences instrumentation market by technique and is likely to retain dominance over the forecast period due to its widespread use. Spectroscopy accounted for 29.4% of the global life sciences instrumentation market in 2017 and is likely to retain a similar level of dominance over the forecast period.

Geographically, North America is likely to dominate the global life sciences instrumentation market over the coming years due to rapid growth of the life sciences sector in developed countries such as the U.S. The North America market for life sciences instrumentation was valued at US$18.6 bn in 2017 and is likely to rise to more than US$28 bn by 2022. However, Asia Pacific except Japan is expected to exhibit the most promising growth, with the region expected to exhibit a robust 8.6% CAGR over the 2017-2022 forecast period.

Competitive Dynamics

The report describes the competitive dynamics of the global life sciences instrumentation market in detail by profiling the leading players operating in the market. Key players profiled in the report include Becton, Dickinson, and Company, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Perkinelmer Inc., GE Healthcare, Merck KGaA, Bruker Corporation, Hitachi High-Technologies Corporation, Eppendorf AG, and Shimadzu Corporation.


 
 
Back To Top